Indeed, genetic CXCR6 deficiency is protective in mouse models of arthritis (49), and antibody-mediated blockade of CXCR6 or CXCL16 ameliorates disease in a mouse model of MS (50, 51). This evidence concerns the gene CXCL16 and myeloid sarcoma.